Measuring clinical response and remission in juvenile idiopathic arthritis

Current Opinion in Rheumatology

Volumn 19, Issue 5, 2007, Pages 471-476

  Ringold, Sarah ^a   Wallace, Carol A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

ACR pediatric response criteria; Disease activity score; Health related quality of life; Juvenile idiopathic arthritis; Outcome measures

Indexed keywords

BIOLOGICAL MARKER;

DISEASE ACTIVITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HEALTH STATUS; HUMANS; QUALITY OF LIFE; RECOVERY OF FUNCTION; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34548301943     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32825a6a68     Document Type: Review

References (39)

1. Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897; 80:47-59.
2. Graham TB, Lovell DJ. Outcome in pediatric rheumatic disease. Curr Opin Rheumatol 1997; 9:434-439.
3. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998; 25:198-199.
4. Bombardier C, Tugwell P. A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol 1982; 9:753-757.
5. Fletcher R, Fletcher S. Clinical epidemiology: the essentials. Baltimore: Lippincott Williams & Wilkins; 2005.
6. Palmisani E, Solari N, Magni-Manzoni S, et al. Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. Arthritis Rheum 2006; 55:843-849.
7. Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004; 7:79-92.
8. Eiser C, Mohay H, Morse R. The measurement of quality of life in young children. Child Care Health Dev 2000; 26:401-414.
9. Brunner HI, Klein-Gitelman MS, Miller MJ, et al. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 2004; 51:763-773.
10. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40:1202-1209.
11. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. Jama 2005; 294:1671-1684.
12. Lovell DJ, Giannini EH, Reiff A, et al. Pediatric Rheumatology Collaborative Study Group. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003; 48:218-226.
13. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20:579-581.
14. Ritchie DM, Boyle JA, McInnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37:393-406.
15. van Gestel AM, Anderson JJ, van Riel PL, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol 1999; 26:705-711.
16. van Gestel AM, Prevoo ML, van 't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39:34-40.
17. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23 (5 Suppl 39):S93-S99.
18. Lurati A, Pontikaki I, Teruzzi B, et al. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or antitumor necrosis factor alpha agents. Arthritis Rheum 2006; 54:1602-1607. This paper assesses the correlation between the ACR Pediatric 20, ACR Pediatric 30, the DAS, and the DAS28 and indicates that the DAS has good correlation with the ACR Pediatric 30.
19. Brunner HI, et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002; 29:1058-1064.
20. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290-2294.
21. Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52:3554-3562.
22. Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54:3761-3773. The investigators report that the majority of their adult patients with rheumatoid arthritis had evidence of synovitis or bone edema on MRI, despite being considered to have inactive disease by a physician.
23. Oen K, Reed M, Malleson PN, et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003; 30:832-840.
24. Rossi F, Di Dia F, Galipò O, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 2006; 55:717-723.
25. Poznanski AK, Hernandez RJ, Guire KE, et al. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology 1978; 129:661-668.
26. Johnson K. Imaging of juvenile idiopathic arthritis. Pediatr Radiol 2006; 36:743-758.
27. Gylys-Morin VM, Graham TB, Blebea JS, et al. Knee in early juvenile rheumatoid arthritis: MR imaging findings. Radiology 2001; 220:696-706.
28. McQueen FM, Benton N, Crabbe J, et al. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001; 60:859-868.
29. El-Miedany YM, Housny IH, Mansour HM, et al. Ultrasound versus MRI in the evaluation of juvenile idiopathic arthritis of the knee. Joint Bone Spine 2001; 68:222-230.
30. Peake NJ, Khawaja K, Myers A, et al. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology (Oxford) 2005; 44:1383-1389.
31. Braun-Moscovici Y, Markovits D, Zinder O, et al. Anti-cyclic citrullinated protein antibodies as a predictor of response to antitumor necrosis factor-alpha therapy in patients with rheumatoid arthritis. J Rheumatol 2006; 33:497-500.
32. Jarvis JN. Gene expression profiling in pediatric rheumatic disease: what have we learned? What can we learn? Curr Opin Rheumatol 2005; 17:606-611.
33. Phelan JD, Thompson SD. Genomic progress in pediatric arthritis: recent work and future goals. Curr Opin Rheumatol 2006; 18:482-489.
34. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3:329-341.
35. Varni JW, Seid M, Smith Knight T, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002; 46:714-725.
36. Tennant A, Kearns S, Turner F, et al. Measuring the function of children with juvenile arthritis. Rheumatology (Oxford) 2001; 40:1274-1278.
37. Duffy CM. Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. Pediatr Clin North Am 2005; 52:359-372.
38. Oliveira S, Ravelli A, Pistorio A, et al. The Pediatric Rheumatology International Trials Organization (PRINTO). Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. Arthritis Rheum 2007; 57:35-43. This is a survey of proxy reports of quality of life from a large cohort of children with JIA and a control group. Children with JIA were reported to have lower scores in the physical and psychosocial domains than the healthy controls.
39. Gutierrez-Suarez R, Pistorio A, Cespedes Cruz A, et al. Pediatric Rheumatology International Trials Organization (PRINTO). Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) 2007; 46:314-320.